Raptor secures funds to wrap talons around TorreyPines
This article was originally published in Scrip
Executive Summary
Raptor Pharmaceuticals has raised around $5 million through a private placement to fund its proposed merger with TorreyPines Therapeutics as well as its late-stage drug portfolio.